Medical News

RSS

Academic scientist receives $125,000 from ADDF/LBDA program to study LBD

The Alzheimer's Drug Discovery Foundation and the Lewy Body Dementia Association announced today the recipient of their first partnership research award through the Lewy Body Dementia Biomarker Research Program.

12 May 2010

Meda acquires European rights to new imiquimod formulation for AK from Graceway Pharmaceuticals

“We have very good experience with Aldara in Europe and we look forward to provide AK patients with a new product with improved tolerability that builds on the efficacy of imiquimod”

12 May 2010

Benefits outweigh risks in myeloablative therapy for children with high-risk neuroblastoma

Neuroblastoma is among the most common of childhood cancers and fortunately, some children will get better spontaneously. Yet for children with high-risk disease the outlook is poor: more than half will relapse despite chemotherapy.

12 May 2010

BioGenes study documents insufficient sensitivity of ELISA-based generic HCP assay

BioGenes GmbH, a supplier of GMP-compliant immunoassays and antibodies, completed a study that documents the insufficient sensitivity of an ELISA-based generic host cell protein assay. The results confirm the observation of several contract manufacturers that generic HCP assays are only of limited use for detection of HCPs during manufacturing processes.

12 May 2010

Caffeine helps shift workers make fewer errors: Cochrane researchers

Caffeine can help those working shifts or nights to make fewer errors, according to a new study by Cochrane researchers. The findings have implications for health workers and for any industry relying on shift or night work, such as transportation.

12 May 2010

Gamma Knife stereotactic radiosurgery safe for treating children with arteriovenous malformations: Study

A new Mayo Clinic study has found that Gamma Knife™ stereotactic radiosurgery is a safe and effective option for selected children with arteriovenous malformations. This study was presented at the American Association of Neurological Surgeons Annual Meeting in Philadelphia last week.

12 May 2010

NiKem Research receives Italian authorization to perform toxicology studies of NCEs in rodents

NiKem Research is pleased to announce that it has received on March 29th 2010, from the Italian Ministry of Health (Decree N. 69/2010-B), the authorization to perform acute and sub-chronic toxicology studies (upto 28 days) in all rodent species for preliminary safety evaluation of novel chemical entities (NCEs). Toxicokinetic (TK) studies are also allowed to correlate plasma and/or organ exposure of NCEs (and metabolites) to tolerated doses in toxicology studies.

12 May 2010

Gap between Hispanic and white asthma sufferers widen in the use daily medications

The gap between the proportion of black and white Americans with asthma who took an inhaled or oral medicine daily to prevent attacks grew wider between 2003 and 2006, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.

12 May 2010

Periodontal disease treatment reduces blood sugar levels in Type 2 diabetes patients

A study to be published in the latest issue of The Cochrane Library and led by researchers at the University of Edinburgh and supported by colleagues at the Peninsula Dental School, the University of Ottawa and UCL Eastman Dental Institute, suggests that the treatment of serious gum (periodontal) disease in diabetics with Type 2 diabetes may lower their blood sugar levels.

12 May 2010

3M Healthcare Data Dictionary to be integrated with CitiusTech's BI-Clinical business intelligence framework

CitiusTech, a leading provider of healthcare technology solutions and services, has signed an agreement with 3M Health Information Systems to integrate the 3M(TM) Healthcare Data Dictionary with CitiusTech's BI-Clinical healthcare business intelligence framework. The agreement will enable BI-Clinical clients to leverage the robust capabilities of the 3M Healthcare Data Dictionary for enhanced terminology mapping across source systems.

12 May 2010

Children who eat lunch as part of NSLP have increased likelihood of becoming overweight: Research

With obesity becoming an epidemic among school-aged children in this country, a Georgia State University professor has found a link between overweight children and federal school nutrition programs.

12 May 2010

Biotage extends peptide synthesis research collaboration with University of Copenhagen

Biotage, a leading supplier of tools and technology for medicinal and analytical chemistry, announced an agreement to extend the research collaboration with Professor Knud J. Jensen at the Faculty of Life Sciences, University of Copenhagen, to develop new applications on the Biotage Syro Wave in the field of synthetic peptide and protein chemistry. The collaboration builds on Professor Jensen's previous research in developing novel chemistries for and applications of solid-phase peptide synthesis.

12 May 2010

Daily dose of iron reduces breath-holding spells in children by 90%: Studies

An estimated one in 20 kids suffer from breath-holding spells, which come when they are upset, in pain or surprised. In some cases, the children twitch and jerk around involuntarily, as if they are having a seizure. Their faces sometimes turn blue or pale and they often faint.

12 May 2010

Health leaders from sub-Saharan Africa gather for three-day conference on family planning in Kenya

A three-day conference exploring ways to increase access to family planning services in Africa kicked off in Nairobi, Kenya, on Tuesday, Capital FM reports. The meeting, which is hosted by USAID, will bring together "USAID's partners in sub-Saharan Africa who include Angola, Burundi, [Democratic Republic of Congo], Ethiopia, Guinea, Kenya, Nigeria, South Sudan and Tanzania," to work to identify gaps in reproductive and family planning services and address ways to reach out to populations in need, the news service writes (Karong'o, 5/11).

12 May 2010

Response Genetics, GSK sign non-exclusive license agreement for BRAF mutational analysis technology

Response Genetics, Inc., a company focused on the development and sale of molecular diagnostic tests for cancer, today announced it has signed a non-exclusive license agreement with GlaxoSmithKline ("GSK"). Under the terms of the agreement, GSK gains certain rights to Response Genetics' proprietary PCR analysis technology and diagnostic expertise to assess BRAF gene mutations in human tumor samples. Payments will be made to Response Genetics upon achivement of agreed-to milestones.

12 May 2010

Computerized bilingual decision aid can prompt Hispanic smokers to quit: Study

A computerized bilingual decision aid - placed in safety-net clinics and health fairs - can prompt Hispanic and other smokers to set a quit date and choose effective treatments.

12 May 2010

Researchers discover molecular mechanism behind smoking cessation effect

The tobacco addiction epidemic is a major public health problem worldwide. Professor Zhao Baolu and his group from the State Key Laboratory of Brain and Cognitive Science, Institute of Biophysics, Chinese Academy of Sciences set out to tackle this problem. After 20 years of innovative research, they have developed a novel tea filter to treat cigarette addiction and have discovered the molecular mechanism behind the smoking cessation effect.

12 May 2010

meridianEMR launches UROAnalytics tool

meridianEMR, Inc., a leading provider of electronic health records systems and advanced healthcare analytics for urology and surgical practices, today has announced the launch of its exclusive multi-dimensional clinical analysis tool – UROAnalytics.

12 May 2010

Optivia Biotechnology launches OptiDDI Suite for assessing transporter-related DDIs

Optivia Biotechnology Inc., a leading provider of in vitro transporter assay services, today announced the launch of the OptiDDITM Suite, a novel assay panel that assesses the most clinically significant transporter-related drug-drug interactions (DDIs), as identified by the International Transporter Consortium (ITC) in its report "Membrane Transporters in Drug Development" (Nature Reviews-Drug Discovery, March 2010).

12 May 2010

New computer-based tool developed to benefit cancer patients

Cancer patients and doctors are finally getting on the same page about cancer survivorship, thanks to a free new tool that can benefit anyone who has been diagnosed with cancer.

12 May 2010

Medical News

Academic scientist receives $125,000 from ADDF/LBDA program to study LBD

Meda acquires European rights to new imiquimod formulation for AK from Graceway Pharmaceuticals

Benefits outweigh risks in myeloablative therapy for children with high-risk neuroblastoma

BioGenes study documents insufficient sensitivity of ELISA-based generic HCP assay

Caffeine helps shift workers make fewer errors: Cochrane researchers

Gamma Knife stereotactic radiosurgery safe for treating children with arteriovenous malformations: Study

NiKem Research receives Italian authorization to perform toxicology studies of NCEs in rodents

Gap between Hispanic and white asthma sufferers widen in the use daily medications

Periodontal disease treatment reduces blood sugar levels in Type 2 diabetes patients

3M Healthcare Data Dictionary to be integrated with CitiusTech's BI-Clinical business intelligence framework

Children who eat lunch as part of NSLP have increased likelihood of becoming overweight: Research

Biotage extends peptide synthesis research collaboration with University of Copenhagen

Daily dose of iron reduces breath-holding spells in children by 90%: Studies

Health leaders from sub-Saharan Africa gather for three-day conference on family planning in Kenya

Response Genetics, GSK sign non-exclusive license agreement for BRAF mutational analysis technology

Computerized bilingual decision aid can prompt Hispanic smokers to quit: Study

Researchers discover molecular mechanism behind smoking cessation effect

meridianEMR launches UROAnalytics tool

Optivia Biotechnology launches OptiDDI Suite for assessing transporter-related DDIs

New computer-based tool developed to benefit cancer patients

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Evolving spectrophotometry for modern biopharma workflows

Latest News